Quantcast
Channel: Wayne Rhoads – Zolmax
Viewing all articles
Browse latest Browse all 193099

AMETEK (NYSE:AME) Issues Q2 2021 Earnings Guidance

$
0
0

AMETEK logoAMETEK (NYSE:AME) updated its second quarter 2021 earnings guidance on Tuesday. The company provided EPS guidance of 1.080-1.100 for the period, compared to the Thomson Reuters consensus EPS estimate of $1.040. The company issued revenue guidance of -.AMETEK also updated its FY 2021 guidance to 4.480-4.560 EPS.

Shares of AMETEK stock traded down $1.86 during trading on Tuesday, reaching $132.08. The stock had a trading volume of 613,455 shares, compared to its average volume of 1,021,194. The company has a current ratio of 1.88, a quick ratio of 1.47 and a debt-to-equity ratio of 0.40. The company has a market capitalization of $30.50 billion, a price-to-earnings ratio of 34.94, a P/E/G ratio of 3.73 and a beta of 1.36. The stock has a fifty day moving average price of $133.02 and a two-hundred day moving average price of $122.25. AMETEK has a 52 week low of $82.64 and a 52 week high of $139.07.

AMETEK (NYSE:AME) last announced its earnings results on Monday, May 3rd. The technology company reported $1.07 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $1.01 by $0.06. The business had revenue of $1.22 billion for the quarter, compared to analyst estimates of $1.17 billion. AMETEK had a return on equity of 16.29% and a net margin of 18.77%. AMETEK’s revenue for the quarter was up 1.1% compared to the same quarter last year. During the same quarter last year, the firm earned $1.02 EPS. On average, equities analysts forecast that AMETEK will post 3.9 EPS for the current fiscal year.

The company also recently announced a quarterly dividend, which will be paid on Wednesday, June 30th. Shareholders of record on Monday, June 14th will be paid a $0.20 dividend. This represents a $0.80 annualized dividend and a yield of 0.61%. The ex-dividend date of this dividend is Friday, June 11th. AMETEK’s payout ratio is 19.09%.

Several equities research analysts have commented on the company. DA Davidson boosted their target price on AMETEK from $135.00 to $157.00 and gave the company a buy rating in a research note on Wednesday, May 5th. Morgan Stanley boosted their target price on AMETEK from $135.00 to $151.00 and gave the company an overweight rating in a research note on Tuesday, May 11th. Wells Fargo & Company boosted their target price on AMETEK from $160.00 to $170.00 and gave the company an overweight rating in a research note on Wednesday, May 5th. KeyCorp upped their price objective on AMETEK from $141.00 to $150.00 and gave the stock an overweight rating in a research note on Tuesday, May 11th. Finally, Rosenblatt Securities upped their price objective on AMETEK from $140.00 to $142.00 and gave the stock a buy rating in a research note on Tuesday, March 30th. One equities research analyst has rated the stock with a hold rating and seven have assigned a buy rating to the stock. The company currently has a consensus rating of Buy and a consensus price target of $144.29.

In related news, insider Thomas C. Marecic sold 19,240 shares of the business’s stock in a transaction that occurred on Friday, March 26th. The stock was sold at an average price of $125.70, for a total transaction of $2,418,468.00. Following the transaction, the insider now directly owns 46,646 shares of the company’s stock, valued at approximately $5,863,402.20. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director Anthony James Conti sold 740 shares of the business’s stock in a transaction that occurred on Thursday, March 25th. The stock was sold at an average price of $121.43, for a total value of $89,858.20. Following the transaction, the director now directly owns 25,538 shares in the company, valued at $3,101,079.34. The disclosure for this sale can be found here. In the last quarter, insiders have sold 38,258 shares of company stock worth $4,825,035. Company insiders own 0.74% of the company’s stock.

AMETEK Company Profile

AMETEK, Inc manufactures and sells electronic instruments and electromechanical devices worldwide. It operates in two segments, Electronic Instruments (EIG) and Electromechanical (EMG). The company's EIG segment offers advanced instruments for the process, aerospace, power, and industrial markets; process and analytical instruments for the oil and gas, petrochemical, pharmaceutical, semiconductor, automation, and food and beverage industries; and instruments to the laboratory equipment, ultra-precision manufacturing, medical, and test and measurement markets.

Featured Story: Bear Market

Earnings History and Estimates for AMETEK (NYSE:AME)


Viewing all articles
Browse latest Browse all 193099

Trending Articles